Reference
1. Moosburner S, Gassner JMGV, Nösser M, Pohl J, Wyrwal D, Claussen F, Ritschl P V., Dragun D, Pratschke J, Sauer IM, Raschzok N. Prevalence of steatosis hepatis in the eurotransplant region: Impact on graft acceptance rates. HPB Surg, 2018, 20182. Orman ES, Barritt AS, Wheeler SB, Hayashi PH. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transplant, 2013, 19:59–683. Linares I, Hamar M, Selzner N, Selzner M. Steatosis in Liver Transplantation: Current Limitations and Future Strategies. Transplantation, 2019, 103:78–904. deLemos AS, Vagefi PA. Expanding the donor pool in liver transplantation: Extended criteria donors. Clin Liver Dis, 2013, 25. Volk ML, Roney M, Merion RM. Systematic bias in surgeons’ predictions of the donor-specific risk of liver transplant graft failure. Liver Transplant, 2013, 19:987–906. Jackson KR, Motter JD, Haugen CE, Holscher C, Long JJ, Massie AB, Philosophe B, Cameron AM, Garonzik-Wang J, Segev DL. Temporal trends in utilization and outcomes of steatotic donor livers in the United States. Am J Transplant, 2020, 20:855–637. Spitzer AL, Lao OB, Dick AAS, Bakthavatsalam R, Halldorson JB, Yeh MM, Upton MP, Reyes JD, Perkins JD. The biopsied donor liver: Incorporating macrosteatosis into high-risk donor assessment. Liver Transplant, 2010, 16:874–848. Graham JA, Guarrera J V. “resuscitation” of marginal liver allografts for transplantation with machine perfusion technology. J Hepatol, 2014, 619. Muhammad H, Zaffar D, Tehreem A, Ting PS, Simsek C, Turan I, Alqahtani S, Saberi B, Gurakar A. An update on usage of high-risk donors in liver transplantation. J Clin Med, 2022, 1110. Kwong AJ, Kim WR, Lake J, Stock PG, Wang CJ, Wetmore JB, Melcher ML, Wey A, Salkowski N, Snyder JJ, Israni AK. Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome. Transplantation, 2023, 10711. Cesaretti M, Addeo P, Schiavo L, Anty R, Iannelli A. Assessment of Liver Graft Steatosis: Where Do We Stand? Liver Transplant, 2019, 25:500–912. Neil DAH, Minervini M, Smith ML, Hubscher SG, Brunt EM, Demetris AJ. Banff consensus recommendations for steatosis assessment in donor livers. Hepatology, 2022, 75:1014–2513. Rajamani AS, Rammohan A, Sai VVR, Rela M. Current techniques and future trends in the diagnosis of hepatic steatosis in liver donors: A review. J Liver Transplant, 2022, 7:10009114. McLaughlin BL, Wells AC, Virtue S, Vidal-Puig A, Wilkinson TD, Watson CJE, Robertson PA. Electrical and optical spectroscopy for quantitative screening of hepatic steatosis in donor livers. Phys Med Biol, 2010, 5515. Le Naour F, Gadea L, Danulot M, Yousef I, Vibert E, Wavelet M, Kaščáková S, Castaing D, Samuel D, Dumas P, Guettier C. Quantitative assessment of liver steatosis on tissue section using infrared spectroscopy. Gastroenterology, 2015, 14816. Golse N, Cosse C, Allard MA, Laurenzi A, Tedeschi M, Guglielmo N, Fernandez-Sevilla E, Robert M, Tréchot B, Pietrasz D, Pittau G, Ciacio O, Sa Cunha A, Castaing D, Cherqui D, Adam R, Samuel D, Sebagh M, Vibert E. Evaluation of a micro-spectrometer for the real-time assessment of liver graft with mild-to-moderate macrosteatosis: A proof of concept study. J Hepatol, 2019, 70:423–3017. Evers DJ, Westerkamp AC, Spliethoff JW, Pully V V., Hompes D, Hendriks BHW, Prevoo W, Van Velthuysen MLF, Porte RJ, Ruers TJM. Diffuse reflectance spectroscopy: Toward real-time quantification of steatosis in liver. Transpl Int, 2015, 2818. Reistad N, Nilsson JH, Bergenfeldt M, Rissler P, Sturesson C. Intraoperative liver steatosis characterization using diffuse reflectance spectroscopy. HPB, 2019, 2119. Butler HJ, Ashton L, Bird B, Cinque G, Curtis K, Dorney J, Esmonde-White K, Fullwood NJ, Gardner B, Martin-Hirsch PL, Walsh MJ, McAinsh MR, Stone N, Martin FL. Using Raman spectroscopy to characterize biological materials. Nat Protoc, 2016, 11:664–8720. Hewitt KC, Ghassemi Rad J, McGregor HC, Brouwers E, Sapp H, Short MA, Fashir SB, Zeng H, Alwayn IP. Accurate assessment of liver steatosis in animal models using a high throughput Raman fiber optic probe. Analyst, 2015, 140:6602–921. Pacia MZ, Czamara K, Zebala M, Kus E, Chlopicki S, Kaczor A. Rapid diagnostics of liver steatosis by Raman spectroscopy via fiber optic probe: a pilot study. Analyst, 2018, 143:4723–3122. Szafraniec E, Tott S, Kus E, Augustynska D, Jasztal A, Filipek A, Chlopicki S, Baranska M. Vibrational spectroscopy-based quantification of liver steatosis. Biochim Biophys Acta - Mol Basis Dis, 2019, 186523. Majzner K, Kochan K, Kachamakova-Trojanowska N, Maslak E, Chlopicki S, Baranska M. Raman imaging providing insights into chemical composition of lipid droplets of different size and origin: in hepatocytes and endothelium. Anal Chem, 2014, 86:6666–7424. Szafraniec E, Kus E, Wislocka A, Kukla B, Sierka E, Untereiner V, Sockalingum GD, Chlopicki S, Baranska M. Raman spectroscopy–based insight into lipid droplets presence and contents in liver sinusoidal endothelial cells and hepatocytes. J Biophotonics, 2019, 1225. Minamikawa T, Ichimura-Shimizu M, Takanari H, Morimoto Y, Shiomi R, Tanioka H, Hase E, Yasui T, Tsuneyama K. Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy. Sci Rep, 2020, 1026. Guo H, Tikhomirov AB, Mitchell A, Alwayn IPJ, Zeng H, Hewitt KC. Real-time assessment of liver fat content using a filter-based Raman system operating under ambient light through lock-in amplification. Biomed Opt Express, 2022, 13:5231–4527. Nahon JE, Groeneveldt C, Geerling JJ, van Eck M, Hoekstra M. Inhibition of protein arginine methyltransferase 3 activity selectively impairs liver X receptor-driven transcription of hepatic lipogenic genes in vivo. Br J Pharmacol, 2018, 17528. de Jong LM, Zhang Z, den Hartog Y, Sijsenaar TJP, Martins Cardoso R, Manson ML, Hankemeier T, Lindenburg PW, Salvatori DCF, Van Eck M, Hoekstra M. PRMT3 inhibitor SGC707 reduces triglyceride levels and induces pruritus in Western-type diet-fed LDL receptor knockout mice. Sci Rep, 2022, 1229. Out R, Hoekstra M, Hildebrand RB, Kruit JK, Meurs I, Li Z, Kuipers F, Van Berkel TJC, Van Eck M. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol, 2006, 2630. Scientific American MasterTech. Oil Red O Stain Procedure, 2019:1–4. https://www.statlab.com/pdfs/ifu/storo.pdf. (accessed July 24, 2023)31. Ramírez-Zacarías JL, Castro-Muñozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O. Histochemistry, 1992, 9732. Riva G, Villanova M, Cima L, Ghimenton C, Bronzoni C, Colombari R, Crestani M, Sina S, Brunelli M, D’Errico A, Montin U, Novelli L, Eccher A. Oil Red O Is a Useful Tool to Assess Donor Liver Steatosis on Frozen Sections During Transplantation. Transplant Proc, 2018, 5033. Levene AP, Kudo H, Thursz MR, Anstee QM, Goldin RD. Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver? Hepatology, 2010, 5134. Abdelmalek MF. Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver? Reply. Hepatology, 2010, 5135. Choi SS, Diehl AM. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr Opin Lipidol, 2008, 19:295–30036. van Staveren HJ, Moes CJM, van Marie J, Prahl SA, van Gemert MJC. Light scattering in lntralipid-10% in the wavelength range of 400–1100 nm. Appl Opt, 1991, 3037. Kuwashiro T, Takahashi H, Hyogo H, Ogawa Y, Imajo K, Yoneda M, Nakahara T, Oeda S, Tanaka K, Amano Y, Ogawa S, Kawaguchi A, Aishima S, Kage M, Chayama K, Nakajima A, Eguchi Y. Discordant pathological diagnosis of non-alcoholic fatty liver disease: A prospective multicenter study. JGH Open, 2020, 438. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg, 2009, 250:691–6
Supplementary materials